These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22228571)

  • 1. A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro.
    Sun J; Zhang C; Liu G; Liu H; Zhou C; Lu Y; Zhou C; Yuan L; Li X
    Clin Exp Metastasis; 2012 Mar; 29(3):185-96. PubMed ID: 22228571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial screening of binding-peptide of the cell surface marker CD133 of cancer stem cells].
    Sun JM; Zhang C; Li XN
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):476-9. PubMed ID: 18931708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selection and identification of specific-binding peptides for cancer stem cell surface marker CD133].
    Tian PG; Zhou CP; Zhang C; Yang H; Wu XJ; Lu YX; Liu GB; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):761-6. PubMed ID: 21602120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.
    Dong TT; Zhou HM; Wang LL; Feng B; Lv B; Zheng MH
    Ann Surg Oncol; 2011 Jun; 18(6):1797-804. PubMed ID: 21267784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells.
    Chang CJ; Chiang CH; Song WS; Tsai SK; Woung LC; Chang CH; Jeng SY; Tsai CY; Hsu CC; Lee HF; Huang CS; Yung MC; Liu JH; Lu KH
    Childs Nerv Syst; 2012 Mar; 28(3):363-73. PubMed ID: 22249380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive in vivo imaging of tumor-associated CD133/prominin.
    Tsurumi C; Esser N; Firat E; Gaedicke S; Follo M; Behe M; Elsässer-Beile U; Grosu AL; Graeser R; Niedermann G
    PLoS One; 2010 Dec; 5(12):e15605. PubMed ID: 21187924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells.
    Zhang C; Zhou C; Wu XJ; Yang M; Yang ZH; Xiong HZ; Zhou CP; Lu YX; Li Y; Li XN
    Carcinogenesis; 2014 Dec; 35(12):2771-7. PubMed ID: 25269803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
    Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.
    Feng JM; Miao ZH; Jiang Y; Chen Y; Li JX; Tong LJ; Zhang J; Huang YR; Ding J
    Cancer Biol Ther; 2012 Dec; 13(14):1396-406. PubMed ID: 22954703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C
    PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
    Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y
    PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
    Lin L; Liu A; Peng Z; Lin HJ; Li PK; Li C; Lin J
    Cancer Res; 2011 Dec; 71(23):7226-37. PubMed ID: 21900397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and genetic characteristics of tumor-initiating cells in colon cancer.
    Ieta K; Tanaka F; Haraguchi N; Kita Y; Sakashita H; Mimori K; Matsumoto T; Inoue H; Kuwano H; Mori M
    Ann Surg Oncol; 2008 Feb; 15(2):638-48. PubMed ID: 17932721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer.
    Elsaba TM; Martinez-Pomares L; Robins AR; Crook S; Seth R; Jackson D; McCart A; Silver AR; Tomlinson IP; Ilyas M
    PLoS One; 2010 May; 5(5):e10714. PubMed ID: 20502714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
    Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
    BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.